FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1640409 · Received March 18, 2010

Report

Report Number
2027969-2010-00312
Event Type
Malfunction
Date Received
March 18, 2010
Date of Event
February 15, 2010
Report Date
March 17, 2010
Manufacturer
BIOSITE INCORPORATED
Product Code
JPA
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DATA ANALYSIS WAS NOT PERFORMED SINCE TESTING TIME EXCEEDED THREE HOURS BETWEEN THE TWO READINGS. PER ISSUE COMPLAINT, SAMPLES WERE PERFORMED WITHIN 8 HOURS OF EACH OTHER. SINCE TIME OF TEST EXCEEDED THREE HOURS, THERE IS A HIGH POSSIBILITY THAT THE DISCREPANCIES ARE DUE TO CHANGES IN THE STATUS OF THE PT. THREE HOURS IS CONSIDERED A REASONABLE LENGTH OF TIME BETWEEN TWO READINGS IN ORDER FOR COMPARISON TO BE VALID. FUNCTIONAL TEST WAS PERFORMED ON RETURNED METER. TEST RESULTS INDICATED THAT PRODUCT DEFICIENCY WAS NOT ESTABLISHED WITH RETURNED METER. AS OF (B) (6) 2010, SEVEN DISCREPANT RESULT COMPLAINTS WERE REPORTED FOR LOT #220376 YIELDING A COMPLAINT RATE OF 0.002%. DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%) NO FURTHER ACTION IS REQUIRED AT THIS TIME. ONGOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS: DATE: (B) (6) 2010, INRATIO: 3.9, LAB: 2.8.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA BIOSITE INCORPORATED 100071 220376

Patients

Seq Age Sex Outcome Treatment
1 NI